Nephrogen
YC S20Curative genetic medicines for kidney diseases
New York City, NY, USAFounded 20225 employeeswww.nephrogenbiotech.com
Team
5
Founded
2022
About
Nephrogen is a Stanford biotech spin-out developing curative genetic medicines for kidney and pancreatic diseases. Kidney disease alone affects 1 in 7 Americans, and neither indication has any approved gene-based therapies. Nephrogen's underlying platform combines AI and high-throughput screening to engineer safer, more efficient, and less expensive gene delivery vehicles for reaching the kidney and pancreas, and has attracted non-dilutive funding from seven major pharmaceutical companies including Merck KGaA, Novartis, and Bristol Myers Squibb.
Tags
No open roles at this time.
Similar Healthcare startups
Kingdom
Clinically-validated ingredients from natural microbes
Health & WellnessFood Tech
Open Jobs —
Team 21
Founded 2020
Liyfe
Digital Nurse to Automate Symptom Assessment and Risk…
SaaSDigital Health
Open Jobs —
Team 2
Founded 2020
CoreCare
Helping healthcare providers reduce administrative costs using AI
B2BWorkflow AutomationEnterprise Software
Open Jobs —
Team 11
Founded 2020
Harmonic Discovery
Multi-targeted therapeutics to treat complex diseases
AI-powered Drug DiscoveryBiotechHealthcare
Open Jobs —
Team 8
Founded 2022